A summary of the conclusions of the PhRMA Workshop on Acceptable Analytical Practices describes equipment qualification practices and guidelines that are designed to help the pharmaceutical industry be consistent in meeting core requirements.
Kenneth W. Sigvardson
Advertisement
Kenneth W. Sigvardson is a director at The DuPont Pharmaceuticals Company, Experimental Station, PO Box 80353, Wilmington, DE 19880-0353.
Articles by Kenneth W. Sigvardson
Advertisement
Latest Updated Articles
- Laboratory Equipment Qualification
Published: October 2nd 2001 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
3
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
4
How AI, Machine Learning, and Large Language Models Enhance Bioanalysis
5
